BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36062458)

  • 1. MRI pattern in acute optic neuritis: Comparing multiple sclerosis, NMO and MOGAD.
    Darakdjian M; Chaves H; Hernandez J; Cejas C
    Neuroradiol J; 2023 Jun; 36(3):267-272. PubMed ID: 36062458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a Latin American cohort.
    Carnero Contentti E; López PA; Criniti J; Pettinicchi JP; Cristiano E; Patrucco L; Bribiesca Contreras E; Gómez-Figueroa E; Flores-Rivera J; Correa-Díaz EP; Toral Granda AM; Ortiz Yepez MA; Gualotuña Pachacama WA; Piedra Andrade JS; Galleguillos L; Tkachuk V; Nadur D; Daccach Marques V; Soto de Castillo I; Casas M; Cohen L; Alonso R; Caride A; Lana-Peixoto M; Rojas JI
    Eur J Neurol; 2022 Mar; 29(3):802-809. PubMed ID: 34799965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.
    Ciotti JR; Eby NS; Brier MR; Wu GF; Chahin S; Cross AH; Naismith RT
    Mult Scler; 2022 Jan; 28(1):49-60. PubMed ID: 33870786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis.
    Mealy MA; Whetstone A; Orman G; Izbudak I; Calabresi PA; Levy M
    J Neurol Sci; 2015 Aug; 355(1-2):59-63. PubMed ID: 26026942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica.
    Ciotti JR; Eby NS; Wu GF; Naismith RT; Chahin S; Cross AH
    Mult Scler Relat Disord; 2020 Oct; 45():102399. PubMed ID: 32702642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica.
    Ambika S; Durgapriyadarshini S; Padmalakshmi K; Noronha V; Arjundas D
    Indian J Ophthalmol; 2022 Jan; 70(1):194-200. PubMed ID: 34937238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease.
    Bianchi A; Cortese R; Prados F; Tur C; Kanber B; Yiannakas MC; Samson R; De Angelis F; Magnollay L; Jacob A; Brownlee W; Trip A; Nicholas R; Hacohen Y; Barkhof F; Ciccarelli O; Toosy AT
    Mult Scler; 2024 May; 30(6):674-686. PubMed ID: 38646958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined brain and anterior visual pathways' MRIs assist in early identification of neuromyelitis optica spectrum disorder at onset of optic neuritis.
    Buch D; Savatovsky J; Gout O; Vignal C; Deschamps R
    Acta Neurol Belg; 2017 Mar; 117(1):67-74. PubMed ID: 27804015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.
    Ramanathan S; Prelog K; Barnes EH; Tantsis EM; Reddel SW; Henderson AP; Vucic S; Gorman MP; Benson LA; Alper G; Riney CJ; Barnett M; Parratt JD; Hardy TA; Leventer RJ; Merheb V; Nosadini M; Fung VS; Brilot F; Dale RC
    Mult Scler; 2016 Apr; 22(4):470-82. PubMed ID: 26163068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptomeningeal Enhancement in Pediatric Anti-Myelin Oligodendrocyte Glycoprotein Antibody Disease, Multiple Sclerosis, and Neuromyelitis Optica Spectrum Disorder.
    Goldman-Yassen A; Lee A; Gombolay G
    Pediatr Neurol; 2024 Apr; 153():125-130. PubMed ID: 38382244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review.
    Cellina M; Fetoni V; Ciocca M; Pirovano M; Oliva G
    Neuroradiol J; 2018 Feb; 31(1):69-82. PubMed ID: 28379073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MOGAD: How It Differs From and Resembles Other Neuroinflammatory Disorders.
    Shahriari M; Sotirchos ES; Newsome SD; Yousem DM
    AJR Am J Roentgenol; 2021 Apr; 216(4):1031-1039. PubMed ID: 32755221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
    Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
    Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating Neuromyelitis Optica-Related and Multiple Sclerosis-Related Acute Optic Neuritis Using Conventional Magnetic Resonance Imaging Combined With Readout-Segmented Echo-Planar Diffusion-Weighted Imaging.
    Lu P; Tian G; Liu X; Wang F; Zhang Z; Sha Y
    J Comput Assist Tomogr; 2018; 42(4):502-509. PubMed ID: 29787495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease.
    Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
    Mult Scler Relat Disord; 2021 Nov; 56():103222. PubMed ID: 34461572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted imaging helps differentiate multiple sclerosis and neuromyelitis optica-related acute optic neuritis.
    Wan H; He H; Zhang F; Sha Y; Tian G
    J Magn Reson Imaging; 2017 Jun; 45(6):1780-1785. PubMed ID: 27859858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI Characteristics of NMO, MOG and MS Related Optic Neuritis.
    Winter A; Chwalisz B
    Semin Ophthalmol; 2020 Nov; 35(7-8):333-342. PubMed ID: 33395326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease.
    Carnero Contentti E; Okuda DT; Rojas JI; Chien C; Paul F; Alonso R
    J Neuroimaging; 2023; 33(5):688-702. PubMed ID: 37322542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS.
    Chen JJ; Sotirchos ES; Henderson AD; Vasileiou ES; Flanagan EP; Bhatti MT; Jamali S; Eggenberger ER; Dinome M; Frohman LP; Arnold AC; Bonelli L; Seleme N; Mejia-Vergara AJ; Moss HE; Padungkiatsagul T; Stiebel-Kalish H; Lotan I; Hellmann MA; Hodge D; Oertel FC; Paul F; Saidha S; Calabresi PA; Pittock SJ
    Mult Scler Relat Disord; 2022 Feb; 58():103525. PubMed ID: 35038647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
    Chen JJ; Bhatti MT
    Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.